Business
Noala, Elion and Upheal also announced funding rounds.
This summer, AIVF announced it had raised $25 million in Series A funding.
A Cerebral spokesperson said the cuts were "focused specifically on realizing operational efficiencies while prioritizing clinical quality and safety across the organization."
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.
The acquisition will expand Unified's portfolio of women-focused companies to include menopause-relief offerings in all 50 states.
During a discussion at the Frontiers Health Global Hybrid Conference, panelists said a more competitive funding environment could push startups and investors to focus on quality.
Genomic testing company Variantyx raised $20 million in debt financing, and mental health provider Mindful Care scooped up $7 million.
The newest offering is spirometry testing to evaluate patients for chronic obstructive pulmonary disease.
The company will distribute AlertWatch to hospitals in the U.S. as part of its strategic partnership with Medtronic.
Calm Health, offered through providers, payers and self-insured employers, builds off the company's acquisition of Ripple Health Group.